SA 16 - Novel therapies require novel imaging: radiologists face cellular therapies, antibodies & Co.
February 28, 16:00 - 17:30 CET
This session is about the requirements diagnostic imaging has to meet in order to support novel oncologic therapies sufficiently. We will briefly cover the spectrum of novel therapeutic approaches and potentially complicating/challenging imaging and discuss the specificities for image-based therapy monitoring and imaging patterns of adverse therapy effects using CT, MRI, and hybrid imaging.
5 min
Chairperson's introduction
15 min
Novel cellular therapies: an overview for radiologists
20 min
Therapy monitoring: hybrid and functional imaging
20 min
Imaging patterns of typical adverse events in CT and MRI
20 min
Imaging patterns of typical adverse events in hybrid imaging